A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy and Safety of Administrated AD-221 and AD-221A in Patients With Primary Hypercholesterolemia

The purpose of this study is to evaluate the efficacy and safety of AD-221 and AD-221A

The purpose of this study is to evaluate the efficacy and safety of AD-221 and AD-221A in patients with primary hypercholesterolemia

Inclusion Criteria:

• Signed informed consent
• Subjects with primary hypercholesterolemia

Exclusion Criteria:

• Patient with secondary dyslipidemia
• Other exclusions applied